3D printing in healthcare market seen nearly doubling by 2030

The Business Research Company projects the global 3D printing in healthcare market will grow from $2.95 billion in 2026 to $5.99 billion by 2030. The forecast points to rising chronic disease rates, more bioprinting investment and broader use of patient-specific medical devices.

Why it matters: - 3D printing is moving deeper into healthcare manufacturing and treatment planning. - The market outlook signals stronger demand for personalized devices, implants and surgical tools. - Chronic disease growth is adding pressure for customized care solutions.

What happened: - The Business Research Company released a 2026 market report on 3D printing in healthcare on July 23, 2026. - The report estimates the market will rise from $2.47 billion in 2025 to $2.95 billion in 2026. - The report projects the market will reach $5.99 billion by 2030. - The forecast implies a 19.3% compound annual growth rate from 2025 to 2026 and 19.4% through 2030. - The report covers market trends, segments, regional growth and future applications. - More information is available in the full report.

The details: - 3D printing in healthcare uses layer-by-layer manufacturing from digital designs for medical purposes. - The technology is used for patient-specific medical devices, anatomical models, customized surgical instruments and surgery planning. - Growth drivers include advances in additive manufacturing, early use of 3D printed surgical guides, academic research, broader use of anatomical models and more printable biomaterials. - The report says rising funding and investment in bioprinting research will help drive future growth. - Other growth factors include demand for personalized healthcare products, expanding regenerative medicine use, point-of-care manufacturing and more regulatory approvals for printed medical devices. - Expected trends include more patient-specific medical devices, bioprinting technologies, customized surgical models, 3D printed implants and prosthetics, and tighter links between digital design and manufacturing. - North America held the largest market share in 2025. - Asia Pacific is expected to be the fastest-growing region during the forecast period. - The report also examines South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - Chronic disease growth is a major demand driver because personalized implants and devices can better match individual treatment needs. - The report cites UK National Health Service data showing 3,615,330 people registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, up 18% from 3,065,825 in 2022. - That kind of disease burden supports continued investment in medical printing and customized care. - The 2026 report edition adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards and market hotspot infographics.

What's next: - Bioprinting research investment is likely to keep expanding. - More regulatory approvals could accelerate adoption of printed medical devices. - Hospitals and manufacturers may increase use of point-of-care production and patient-specific design workflows. - Asia Pacific's growth trajectory could narrow the gap with North America over time.

The bottom line: - 3D printing in healthcare is shifting from niche adoption toward broader clinical and manufacturing use, with personalization and chronic disease needs driving the next stage of growth.